1. Perlmutter Cancer Center, NYU School of Medicine, New York, New York
2. Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland
3. Columbia University Medical Center, New York, New York
4. Clinical Investigations Branch, Cancer Therapy and Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland
5. Investigational Drug Branch, Cancer Therapy and Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland
6. US Food and Drug Administration, Silver Spring, Maryland
7. Virginia Commonwealth University, Massey Cancer Center, Richmond
8. Cedars-Sinai Medical Center, Los Angeles, California
9. Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
10. Gemini Group, Ann Arbor, Michigan
11. Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, Oregon
12. Department of Medicine, Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, Curriculum in Bioinformatics and Computational Biology, University of North Carolina at Chapel Hill
13. Coordinating Center for Clinical Trials, National Cancer Institute, Rockville, Maryland
14. Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland
15. MD Anderson Cancer Center, Houston, Texas
16. British Columbia Cancer Agency, Vancouver, British Columbia, Canada
17. The Ohio State University Comprehensive Cancer Center, Columbus
18. Montefiore Einstein Center for Cancer Care, New York, New York
19. Fred Hutchinson Cancer Research Center, Seattle, Washington
20. Editor, JAMA Oncology
21. Department of Surgery, Brigham and Women’s Hospital, Boston, Massachusetts
22. Breast Oncology Program, Dana-Farber/Brigham and Women’s Cancer Center, Boston, Massachusetts